MedPath

Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.

Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin. In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths). Opioid overdoses kill an average of 11 Canadians daily.

Fentanyl was FDA approved in 1968.

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.

Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy

Depodur vs Fentanyl Infusion for Post-C/S Analgesia

Not Applicable
Withdrawn
Conditions
Analgesia
Interventions
Drug: Fentanyl
Drug: Depodur
First Posted Date
2008-09-30
Last Posted Date
2022-03-29
Lead Sponsor
Goodman, Evan, M.D.
Registration Number
NCT00762554
Locations
🇺🇸

University Hospitals Case Medical Center, Cleveland, Ohio, United States

Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery

Phase 4
Completed
Conditions
Upper Extremity
Orthopedic Surgery
Trauma
Forearm Injuries
Nerve Block
Interventions
Drug: Midazolam
Drug: Ropivacaine
Drug: Fentanyl
Procedure: General anesthesia
Procedure: Infraclavicular brachial plexus block
Procedure: Axillary brachial plexus nerve block
First Posted Date
2008-07-29
Last Posted Date
2009-07-15
Lead Sponsor
University of Parma
Target Recruit Count
52
Registration Number
NCT00724035
Locations
🇮🇹

University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy

Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants

Phase 3
Completed
Conditions
Pain
Neonatal Infections
Analgesia
Interventions
First Posted Date
2008-07-11
Last Posted Date
2008-07-11
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
160
Registration Number
NCT00713726
Locations
🇧🇷

Albert Sabin Hospital, Fortaleza, Ceará, Brazil

Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function

Phase 4
Completed
Conditions
Lung Function
Interventions
Drug: propofol
Drug: remifentanil
Drug: fentanyl
Drug: Sevoflurane/Nitrous Oxide
First Posted Date
2008-06-27
Last Posted Date
2009-02-10
Lead Sponsor
Medical University Innsbruck
Target Recruit Count
60
Registration Number
NCT00706277
Locations
🇦🇹

TILAK Hospitals, Innsbruck, Austria

Ultrasound Guidance for Interscalene Brachial Plexus Block

Phase 4
Completed
Conditions
Shoulder
Orthopedic Surgery
Nerve Block
Interventions
Procedure: Ultrasound-guided continuous interscalene brachial plexus block
Procedure: Continuous interscalene brachial plexus block using electrical nerve stimulation
Drug: Ropivacaine
Drug: Paracetamol
Drug: Morphine
Drug: Fentanyl
Procedure: General anesthesia
First Posted Date
2008-06-20
Last Posted Date
2009-11-16
Lead Sponsor
University of Parma
Target Recruit Count
50
Registration Number
NCT00702416
Locations
🇮🇹

University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy

Matrifen® for Therapy of Severe Chronic Pain®

Completed
Conditions
Severe Chronic Pain
First Posted Date
2008-06-18
Last Posted Date
2012-05-08
Lead Sponsor
Nycomed
Target Recruit Count
5308
Registration Number
NCT00699335
Locations
🇩🇪

Nycomed Deutschland GmbH, Östringen, Germany

Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain

Phase 1
Completed
Conditions
Pain, Fracture, Sprain
Interventions
First Posted Date
2008-05-28
Last Posted Date
2017-02-09
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
60
Registration Number
NCT00685295
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Dexmedetomidine vs Fentanyl for BMT

Phase 4
Completed
Conditions
Otitis
Interventions
First Posted Date
2008-04-08
Last Posted Date
2011-04-25
Lead Sponsor
Children's National Research Institute
Target Recruit Count
101
Registration Number
NCT00654329
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy

Phase 4
Completed
Conditions
Tonsillitis
Interventions
First Posted Date
2008-04-08
Last Posted Date
2021-03-23
Lead Sponsor
Children's National Research Institute
Target Recruit Count
101
Registration Number
NCT00654511
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain

Phase 3
Completed
Conditions
Pain
Interventions
First Posted Date
2008-03-31
Last Posted Date
2012-09-14
Lead Sponsor
University of Aarhus
Target Recruit Count
22
Registration Number
NCT00647127
Locations
🇩🇰

Mech Sense, Department of Gastroenterology, Aalborg, Region Nordjyllan, Denmark

© Copyright 2025. All Rights Reserved by MedPath